Insider · CIK 0001134106

SANDS ARTHUR T

Reports to the SEC for 2 companies · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001134106

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-10	NRIXNurix Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President, CEO	AAward	+563K sh	—	—	562,500
2025-02-11	NRIXNurix Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President, CEO	AAward	+450K sh	—	—	450,000
2024-02-13	NRIXNurix Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President, CEO	AAward	+800K sh	—	—	800,000
2023-02-14	NRIXNurix Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President, CEO	AAward	+448K sh	—	—	448,000
2022-08-09	NRIXNurix Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President, CEO	AAward	+400K sh	—	—	400,000
2022-01-20	NRIXNurix Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President, CEO	AAward	+300K sh	—	—	300,000
2021-02-11	NRIXNurix Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President, CEO	AAward	+150K sh	—	—	150,000
2020-10-21	NRIXNurix Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO	AAward	+804K sh	—	—	804,170
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+36.3K sh	—	—	979,120
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+37K sh	—	—	1,016,120
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+35K sh	—	—	1,051,120
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	Director, President & CEO	FTax Payment	−29.8K sh	$1.92	−$57.2K	1,021,329
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−36.3K sh	—	—	36,250
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−37K sh	—	—	74,000
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−35K sh	—	—	105,000
2013-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+36.3K sh	—	—	925,904
2013-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+37K sh	—	—	962,904
2013-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	Director, President & CEO	FTax Payment	−20K sh	$1.98	−$39.7K	942,870
2013-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−36.3K sh	—	—	72,500
2013-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−37K sh	—	—	111,000
2013-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	Director, President & CEO	AAward	+140K sh	—	—	140,000
2013-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+560K sh	—	—	560,000
2013-01-31	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+73.7K sh	—	—	911,088
2013-01-31	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	Director, President & CEO	FTax Payment	−21.4K sh	$2.11	−$45.2K	889,654
2013-01-31	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−73.7K sh	—	—	0
2012-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+36.3K sh	—	—	846,976
2012-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	Director, President & CEO	FTax Payment	−9,588 sh	$1.78	−$17.1K	837,388
2012-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−36.3K sh	—	—	108,750
2012-02-15	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	Director, President & CEO	AAward	+148K sh	—	—	148,000
2012-02-15	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+592K sh	—	—	592,000
2011-12-22	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+25K sh	$1.13	+$28.2K	810,726
2011-12-22	LXRXLEXICON PHARMACEUTICALS, INC. · Subscription Rights (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−58.5K sh	—	—	0
2011-02-23	LXRXLEXICON PHARMACEUTICALS, INC.A Award	Director, President & CEO	AAward	+38.7K sh	—	—	796,190
2011-02-23	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	Director, President & CEO	FTax Payment	−10.5K sh	$1.81	−$18.9K	785,726
2011-02-23	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+580K sh	—	—	580,000
2011-02-23	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	Director, President & CEO	AAward	+145K sh	—	—	145,000
2010-02-15	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+765K sh	—	—	765,000
2010-02-15	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	Director, President & CEO	AAward	+73.7K sh	—	—	73,700
2010-02-12	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	Director, President & CEO	FTax Payment	−14.9K sh	$1.91	−$28.4K	757,516
2009-08-12	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	Director, President & CEO	FTax Payment	−13.7K sh	$1.30	−$17.8K	772,388
2009-02-12	LXRXLEXICON PHARMACEUTICALS, INC.A Award	Director, President & CEO	AAward	+103K sh	—	—	786,062
2009-02-12	LXRXLEXICON PHARMACEUTICALS, INC. · Employee Stock Option (right to buy)A Award	Director, President & CEO	AAward	+775K sh	—	—	775,000
2005-02-18	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+150K sh	—	—	150,000
2004-12-28	LXRXLEXICON PHARMACEUTICALS, INC.G Gift	Director, President & CEO	GGift	−2,625 sh	—	—	152,175
2004-12-28	LXRXLEXICON PHARMACEUTICALS, INC.G Gift	Director, President & CEO	GGift	−1,313 sh	—	—	150,862

Recent filings

Accepted (ET)
Feb 104
SANDS ARTHUR T0001134106-26-000002
SEC(opens sec.gov)
Feb 134
SANDS ARTHUR T0001549595-25-000035
SEC(opens sec.gov)
Feb 154
SANDS ARTHUR T0001549595-24-000017
SEC(opens sec.gov)
Feb 154
SANDS ARTHUR T0001209191-23-009710
SEC(opens sec.gov)
Aug 104
SANDS ARTHUR T0001209191-22-045194
SEC(opens sec.gov)
Jan 214
SANDS ARTHUR T0001209191-22-004433
SEC(opens sec.gov)
Feb 124
SANDS ARTHUR T0001209191-21-010442
SEC(opens sec.gov)
Oct 234
SANDS ARTHUR T0001209191-20-055716
SEC(opens sec.gov)
Mar 34
LEXICON PHARMACEUTICALS, INC./DE0001127602-14-009658
SEC(opens sec.gov)
Mar 14
SANDS ARTHUR T0001127602-13-008839
SEC(opens sec.gov)

Companies

Address

C/O NURIX THERAPEUTICS, INC. 1600 SIERRA POINT PKWY

BRISBANE, CA, 94005